OpGen, Inc. (OPGN) financial statements (2020 and earlier)

Company profile

Business Address 708 QUINCE ORCHARD ROAD
GAITHERSBURG, MD 20878
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments35248
Cash and cash equivalents35248
Receivables30111
Inventory, net of allowances, customer advances and progress billings01111
Inventory01111
Other undisclosed current assets00001
Total current assets:764610
Noncurrent Assets
Finance lease, right-of-use asset1
Operating lease, right-of-use asset1
Property, plant and equipment01111
Intangible assets, net (including goodwill)12223
Goodwill11111
Intangible assets, net (excluding goodwill)11122
Other noncurrent assets00000
Total noncurrent assets:43334
TOTAL ASSETS:1097914
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34444
Accounts payable12222
Accrued liabilities11111
Employee-related liabilities11111
Deferred revenue0
Debt21110
Deferred revenue and credits000
Contract with customer, liability0
Total current liabilities:54555
Noncurrent Liabilities
Long-term debt and lease obligation11001
Long-term debt, excluding current maturities01  1
Finance lease, liability0
Capital lease obligations0000
Operating lease, liability1
Liabilities, other than long-term debt 000 
Deferred revenue and credits00 
Deferred rent credit 0
Other undisclosed noncurrent liabilities 00  
Total noncurrent liabilities:11011
Total liabilities:66566
Stockholders' equity
Stockholders' equity attributable to parent43137
Common stock00000
Additional paid in capital179165150136121
Accumulated other comprehensive income (loss)(0)(0)(0)0(0)
Accumulated deficit(175)(162)(149)(133)(114)
Total stockholders' equity:43137
TOTAL LIABILITIES AND EQUITY:1097914

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues33343
Revenue, net343
Cost of revenue(2)(1)(2)(2)(0)
Cost of goods and services sold  (2)(2)(0)
Gross profit:11123
Operating expenses(14)(15)(16)(21)(18)
Other undisclosed operating income    0
Operating loss:(12)(13)(15)(19)(15)
Nonoperating expense(0)(0)(0)(0)(2)
Foreign currency transaction gain (loss), before tax0(0)0(0) 
Interest and debt expense(0)(0)(0)(0)(2)
Loss from continuing operations before equity method investments, income taxes:(13)(14)(16)(19)(19)
Other undisclosed income from continuing operations before income taxes00002
Loss from continuing operations before income taxes:(12)(13)(15)(19)(17)
Income tax benefit    0
Net loss attributable to parent:(12)(13)(15)(19)(17)
Preferred stock dividends and other adjustments   (0) 
Other undisclosed net loss available to common stockholders, basic    (0)
Net loss available to common stockholders, diluted:(12)(13)(15)(19)(18)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(12)(13)(15)(19)(17)
Comprehensive loss:(12)(13)(15)(19)(17)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)0(0)
Comprehensive loss, net of tax, attributable to parent:(12)(13)(15)(19)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: